An intriguing finding was that resveratrol treatment in women with severe obesity increased insulin action and AMPK phosphorylation without changing other components in the AMPK signaling network, such as SIRT1 and PGC1α. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.